News
19
2020-02
February 19th, 2020—BrosMed Medical Co., Ltd. announced CE Mark and launched its Wedge NC Scoring Balloon Catheter and Alveo HP Balloon Catheter . Wedge NC and Alveo HP are for the treatment of Percutaneous Transluminal Coronary Angioplasty (PTCA) by improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
2020-02-19
19
2020-01
February 19th, 2020—BrosMed Medical Co., Ltd. announced CE Mark and launched its Tri-Wedge PTA Balloon Catheter. Tri-Wedge is a Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Dilatation Catheter, which ideal for Arteriovenous Fistula (AV) Shunt Scoring.
2020-01-19
14
2018-12
December 11st, 2018, Mr. Roy Noda, Asia-Pacific President of Cardinal Health (www.cardinalhealth.com), Ms. Jessie, General Manager in China and their team visited BrosMed Medical
2018-12-14
15
2018-11
The 2018 Dongguan Innovation and Entrepreneurship Competition were held on October 16th in the Dongguan. Brosmed Medical Co., Ltd. ‘s advanced PTA Balloon Catheter project has been won the Champion in the Growing Group.
2018-11-15
24
2018-10
October 11th to 14th, 2018, the 29th Great Wall International Cardiology Conference (GW-ICC) was held in Beijing National Convention Center. In the theme of “Healthy Heart, striving Life”, this year’s GW-ICC set up 507 conference lectures, 30 training workshops, 35 special conferences; 54 joint forums with 15 foreign societies and organizations. More than 2,000 domestic experts, and 300 international experts participated the academic tasks. The number of forums and the large lineup of experts are the highest among all GW-ICC.
2018-10-24
28
2018-06
23rd-24th June 2018, The Third China Summit for Retrograde Percutaneous Recanalization of Chronic Total Occlusion (RPR-CTO Summit 2018), which was hosted by Guangdong Medical Doctor Association and Guangdong Interventional Cardiology Association and organized by Guangdong People’ Hospital, was successfully convened at Dong Fang Hotel, Guangzhou China.
2018-06-28
03
2018-05
BrosMed Medical Announces Completes Successful FDA Inspection
Brosmed, Dongguan., April 28, 2018–Brosmed Medical Co. ,Ltd, a leading provider of medical device of cardiovascular and endovascular since 2012, is pleased to announce it successfully completed 4 days Quality System/Current Good Manufacturing Practice regulations for medical devices (21 CFR Part 820) inspection from FDA. This comes as a result of Brosmed medical 5 years ongoing commitment to the highest levels of quality standards.
2018-05-03
11
2018-01
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA October 27th, 2017—BrosMed Medical announced CE Mark and Launched its Wedge™ Scoring PTCA Balloon for the treatment of percutaneous transluminal coronary angioplasty (PTCA) for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
2018-01-11